PRESS RELEASE
THE DARK REPORT
21806 Briarcliff Dr.
Spicewood, TX 78669
512-264-7103 o
512-264-0969 f
FOR IMMEDIATE RELEASE
Media Contact: Chris Garcia
chris@darkreport.com
AUSTIN, Texas (June 1, 2018) – Medicine is rapidly shifting from a traditional one-size-fits-all approach to an individualized predictive and personalized medicine model, with care customized for each patient. Uniquely positioned within this shifting healthcare paradigm are molecular and clinical laboratories that can provide healthcare teams with access to a rich repository of actionable genetic data.
Pathologists are becoming the point persons as personalized medicine becomes the norm. With next generation sequencing (NGS) accelerating the pace of discoveries, prevention and treatment will no longer be centered around “standards of care” that result in a predetermined sequence of therapies. Instead, a patient’s genome, lifestyle, and environment will combine to pinpoint an effective and individualized treatment plan.
“Because NGS is the engine powering much of this new genetic information and igniting the potential of personalized medicine, clinical laboratories have an ideal opportunity to add clinical value and generate a new revenue source by adopting NGS technologies,” said Robert L. Michel, Editor-In-Chief of The Dark Report. “But because the NGS modality places significant demands on most current laboratory information systems and leaves them lacking crucial functionality, labs need to have in place a LIMS specifically designed to accommodate personalized medicine’s informatics integration and workflow challenges in order to successfully integrate NGS.”
Addressing the important topic of next-generation sequencing (NGS) is a recently published White Paper from The Dark Report, entitled “How Next-Generation Sequencing Helps Molecular Laboratories Deliver Personalized Medicine Services to their Client Physicians.” Published by The Dark Report and Dark Daily, it is available free to laboratory professionals as a PDF download.
This White Paper discusses the growing role of NGS in clinical care and its potential to fuel the transformation to predictive medicine, as well as pathologists’ contributions to this emerging paradigm and the laboratory information technology and informatics they will need to remain at the forefront of change. Because NGS services represent a major financial commitment by laboratories, the advantages of using NGS testing as a tool to retain and grow a lab’s customer base is also examined.
The paper provides a detailed discussion regarding:
- The growing role of NGS in clinical care
- NGS’ return on investment for clinical and molecular laboratories
- The role of pathologists, as NGS accelerates the transition to predictive and personalized medicine
- The information technology and tools laboratories need to successfully offer NGS-based services
- Benefits of outsourcing annotation and interpretation of gene sequences and test-result reporting
- What clinical and molecular laboratories need to know about marketing NGS services to new and existing clients
Medicine is transforming from reactive to proactive, predictive care—with NGS on the verge of being transformative in many ways as it provides a direction destined to accelerate the shift in care models, and ushers in personalized medicine at the genomic level. Pathologists are uniquely qualified to advance the cause of personalized medicine among regulators, insurers, providers, and patients, but can only do so if the best health informatics technology is at their fingertips. To learn more, download “How Next-Generation Sequencing Helps Molecular Laboratories Deliver Personalized Medicine Services to their Client Physicians” here. This is a free publication of Dark Daily, comprised of a growing library of White Papers and other information resources tailored specifically to the needs of laboratory administrators, lab managers, pathologists, and lab industry consultants.
For additional information, Contact: Chris Garcia at 512-264-7103
About THE DARK REPORT
Established in 1995, THE DARK REPORT is the leading source of exclusive business intelligence for laboratory CEOs, COOs, CFOs, Pathologists and Senior industry executives. It is widely read by leaders in laboratory medicine and diagnostics. The Dark Report produces the famous Executive War College on Laboratory and Pathology Management every spring, which showcases innovations by the nation’s and globe’s leading laboratory organizations. Dark Daily is an Internet-based e-briefing intelligence service, read worldwide by thought leaders in laboratory and pathology management. Other well-known conferences conducted by THE DARK REPORT are Lab Quality Confab (on the use of Lean and Six Sigma methods in labs and hospitals) and Molecular Summit (on the integration of in vivo and in vitro diagnostics). THE DARK REPORT co-produces Frontiers in Laboratory Medicine annually in the United Kingdom; Executive Edge bi-annually in Canada; and The Business of Pathology bi-annually in Australia.
-end-
